Siemens Healthineers AG

Company Snapshot

Founded: 2015
Entity Type: Public
Employees: 74,000
Region: U.S.
Revenue: $25,857.2 Millions
Revenue Year: 2025
Segment: Varian
Headquarter: Forchheim, Germany
Key Geographics: Asia-Pacific, Europe, C.I.S., Americas, Middle East (EMEA)
Corporate Address: Siemensstr. 3, 91301 Forchheim, Germany Tel. +49-9131-84-3385 www.siemens-healthineers.com

Company Overview

Siemens Healthineers AG operates in four business segments: imaging, diagnostics, varian, and advanced therapies. It offers a wide range of diagnostic imaging technologies, including MRI, CT, ultrasound, and X-ray systems. It also has a foothold in laboratory diagnostics, particularly in in vitro diagnostics, which covers a broad spectrum of testing, from routine blood work to advanced genetic testing.

The advanced therapies portfolio features integrated products and services that support image-guided, minimally invasive procedures across cardiology, interventional radiology, and surgery. Major offerings include angiography systems, mobile C-arms, and neurovascular robotics, along with recurring revenue from a solid installed base and service business.

Siemens Healthineers AG has production sites in Germany, the U.S., China, India, Great Britain, and Slovakia, a presence in more than 70 countries, and products available in 180 countries.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Siemens Healthineers AG In Reports

Cardiovascular Devices: Global Markets to 2030

BCC Research detailed report on cardiovascular devices market data using 2024 as the base year 2025 as the estimated year, and provides CAGR projections for the 2025–2030 forecast period.

Bioinformatics: Technologies and Global Markets

BCC Research detailed research report on bioinformatics technology market revenue ($ million) for the base year (2024), estimated data for 2025, and forecast data for 2026 to 2030.

Chronic Kidney Disease: Global Markets and Technologies

BCC Research detailed report on chronic kidney disease market technologies, providing data from 2024, estimates for 2025, projections of compound annual growth rates through 2030.

Company's Business Segments

  • Imaging : Devices for magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound.
  • Diagnostics : Testing disciplines, including immunochemistry, hematology, coagulation, urinalysis, blood gas analysis, and molecular tests.
  • Varian : Multi-modality cancer care technologies based on integrated, advanced imaging, along with solutions and services to oncology departments, integrated equipment and digital solutions.
  • Advanced Therapies : Angiography systems and mobile C-arms.

Applications/End User Industries

  • Theranostics
  • Cardiology
  • Neurology
  • Oncology
  • Surgery
  • Interventional Radiology
  • Hepatology
  • Critical Care
  • Covid-19
  • Women's Health
  • Medical Devices
  • Healthcare
  • Assays by diseases & conditions
AI Sentiment